Fig. 4From: Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patientsKaplan–Meier curves for progression free survival (PFS) of baseline biomarker levels (pg/ml) interacting with sex in the multiple Cox regression model. HR: hazard ratio; CI: confidence intervalBack to article page